Á¦ ¸ñ    HQePFIHPacqlfebrR
ÀÌ ¸§    Tobias ³¯ Â¥    2018/06/29 Á¶ ȸ    7


I'd like to send this letter by trim biofit side effects A number of analysts, including UBS, Barclays and William Blair, have cut their outlooks and share-price targets for Deere in recent days, citing concerns that farmers will slash capital spending as grain prices retreat.